R&D Partner Content 8th Annual Complement-Based Drug Development Summit Achieving Efficacy & Exploring Indication Expansion for Complement Inhibitors
R&D Partner Content 4th Mitochondrial Dysfunction Drug Development Summit Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success
R&D Partner Content 4th annual Rare & Genetic Kidney Disease Drug Development Su... Uncover Disease Pathophysiology, Clarify Response Biomarkers, Leverage Electronic Health Records & Implement Patient-Centric Recruitment Strategies to Accelerate Game-Changing Therapies
R&D Partner Content LEAP HR: Emerging Biopharma Lead The Future in Emerging Biopharma: Revolutionize Your HR Strategy, Develop Top Talent & Empower Your Team to Secure Success Amidst Industry Turbul
R&D Partner Content 15th World ADC San Diego 2024 The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
R&D Partner Content 8th Annual Antifibrotic Drug Development Summit The landmark FDA approval of the first MASH therapeutic, the orphan drug designation for systemic sclerosis trials, and the rapid advancement of IPF treatments through clinical phases have ignited
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
